Maverick Capital Ltd (Lee Ainslie) - Significant Ownership

Notable people
Lee Ainslie
Signature - Title
/s/ Trevor Wiessmann* - By: Maverick Capital Management, LLC, its General Partner By: Lee S. Ainslie III, Manager
Location
Dallas, TX
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Maverick Capital Ltd.

Significant Ownership of Maverick Capital Ltd

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CRIS Curis, Inc. Common Stock, Par Value $0.01 per share 8% $1.08M 681K Maverick Capital, Ltd. Dec 31, 2024
WVE Wave Life Sciences Ltd. $0 Par Value Ordinary Shares 5.4% $56.1M 8.26M Maverick Capital, Ltd. Dec 31, 2024
RCKT Rocket Pharmaceuticals, Inc. Common Stock, $0.01 par value 5.2% $41.2M 5.55M Maverick Capital, Ltd. Apr 7, 2025
VRNA Verona Pharma Plc Ordinary Shares, nominal value 0.05 GBP per share 3.8% $1.64B 25M Maverick Capital, Ltd. Dec 31, 2024

Schedules 13D/G Reported by Maverick Capital Ltd:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.